首页> 外文期刊>Growth hormone and IGF research: Official journal of the Growth Hormone Research Society and the International IGF Research Society >Growth hormone receptor d3-variant, insulin-like growth factor binding protein-1 -575G/A polymorphism and postnatal catch-up growth: association with parameters of glucose homeostasis in former extremely low birth weight preterm infants.
【24h】

Growth hormone receptor d3-variant, insulin-like growth factor binding protein-1 -575G/A polymorphism and postnatal catch-up growth: association with parameters of glucose homeostasis in former extremely low birth weight preterm infants.

机译:生长激素受体d3变异,胰岛素样生长因子结合蛋白-1 -575G / A多态性与产后追赶性生长:与前极低出生体重早产儿葡萄糖稳态的参数相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Low birth weight predisposes to the development of insulin resistance. In addition to auxological parameters such as rapid catch-up growth, low IGFBP-1 serum levels in childhood have been linked to an increased risk of insulin resistance later in life. Concerning postnatal growth, we previously reported the GHRd3-variant to be associated with catch-up growth in preterm infants. In children born small for gestational age, a common IGFBP-1 promoter polymorphism -575G/A has been linked to IGFBP-1 serum levels and has been suggested to be an additional player in the interaction between the IGF-IGFBP-axis and metabolism. STUDY DESIGN: We analyzed postnatal growth, metabolic parameters, and genotypes for the GHRd3-variant and IGFBP-1 -575G/A in 51 former extremely low birth weight preterm infants (mean age 5.9 years). RESULTS: GHRd3 but not IGFBP-1 -575G/A was significantly associated with postnatal growth velocity. Catch-up growth, GHRd3, and IFGBP-1 -575G/A did not influence fasting insulin or HOMA-IR. However, we found significantly higher HbA1c and lower IGFBP-1 concentrations in GHRd3-carriers, a finding not seen with respect to IGFBP-1 -575G/A. Interestingly, HbA1c and IGFBP-1 levels also did not differ between children either with or without catch-up growth. CONCLUSIONS: In addition to an association with catch-up growth, GHR exon 3 genotype significantly modulates HbA1c and IGFBP-1 concentrations in former ELBW infants. In order to confirm this observation and to clarify whether the GHRd3-variant might be considered as an independent modulator of the low birth weight infant's risk to develop insulin resistance later in life, larger studies extending to later ages are required.
机译:背景:低出生体重易导致胰岛素抵抗的发展。除了诸如快速追赶生长的生理学参数外,儿童期低的IGFBP-1血清水平还与后来的胰岛素抵抗风险增加有关。关于产后生长,我们先前曾报道GHRd3变异与早产儿的追赶生长有关。在胎龄小的儿童中,常见的IGFBP-1启动子多态性-575G / A与IGFBP-1血清水平有关,并被认为是IGF-IGFBP轴与新陈代谢之间相互作用的另一个参与者。研究设计:我们分析了51名以前极低出生体重的早产儿(平均年龄5.9岁)的GHRd3变体和IGFBP-1 -575G / A的产后生长,代谢参数和基因型。结果:GHRd3而不是IGFBP-1 -575G / A与产后生长速度显着相关。追赶性生长,GHRd3和IFGBP-1 -575G / A不影响空腹胰岛素或HOMA-IR。但是,我们发现GHRd3携带者中的HbA1c明显较高,而IGFBP-1的浓度较低,这一点对于IGFBP-1 -575G / A而言却没有。有趣的是,无论是否有追赶性生长,儿童之间的HbA1c和IGFBP-1水平也没有差异。结论:除了与追赶生长有关,GHR外显子3基因型显着调节前ELBW婴儿的HbA1c和IGFBP-1浓度。为了确认这一观察结果并阐明GHRd3变体是否可以被认为是低出生体重婴儿生命后期出现胰岛素抵抗风险的独立调节因子,需要进行更大范围的研究,并将其延伸至更高的年龄。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号